Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

trial · primary record

Tofacitinib 5 MG BID

Glucocorticoid Resistant ICIs-related Myocarditis

PhasePhase 2
StatusCOMPLETED
SponsorUnknown
Enrolment25
Primary completion2025-12-16
Primary endpointAll-cause mortality within three months
Registry IDNCT06393972

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:32:34.940Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT06393972

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Tofacitinib 5 MG BID — trial | AEaH